These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Drug-resistant tuberculosis in Cuba. Results of the three global projects. Montoro E, Lemus D, Echemendía M, Armas L, González-Ochoa E, Llanes MJ, Valdivia JA. Tuberculosis (Edinb); 2006; 86(3-4):319-23. PubMed ID: 16569512 [Abstract] [Full Text] [Related]
5. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2006 Mar 24; 55(11):301-5. PubMed ID: 16557213 [Abstract] [Full Text] [Related]
7. Multidrug-resistant tuberculosis (MDR-TB) in India: an attempt to link biosocial determinants. Atre SR, Mistry NF. J Public Health Policy; 2005 Apr 24; 26(1):96-114. PubMed ID: 15906879 [Abstract] [Full Text] [Related]
8. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance. Cox H, Kebede Y, Allamuratova S, Ismailov G, Davletmuratova Z, Byrnes G, Stone C, Niemann S, Rüsch-Gerdes S, Blok L, Doshetov D. PLoS Med; 2006 Oct 24; 3(10):e384. PubMed ID: 17020405 [Abstract] [Full Text] [Related]
9. [Risk of acquisition of RFP resistance out of INH resistant RFP susceptible tuberculosis]. Yoshiyama T, Ito K, Ogata H, Aono A, Wada M. Kekkaku; 2005 Jan 24; 80(1):9-14. PubMed ID: 15839057 [Abstract] [Full Text] [Related]